Medtronic Buying CoreValve for $700 Million+
Medtronic Inc. (NYSE: MDT) has agreed to acquire CoreValve, an Irvine, Calif.-based maker of medical devices for percutaneous heart valve replacement. The deal includes a $700 million up-front payment, plus the possibility of milestone-based earnouts. CoreValve has raised around $63 million in VC funding since 2003, from firms like Apax Partners, HealthCap, Maverick Capital and Sofinnova Partners.
23 February 2009•2 mins read
